4.4 Article

Standards for the development and methodology of the 2019 International Working Group on the Diabetic Foot guidelines

期刊

出版社

WILEY
DOI: 10.1002/dmrr.3267

关键词

diabetic foot; diabetic foot disease; foot ulcer; guidance; guidelines; implementation; IWGDF

资金

  1. MRC [MR/K025643/1] Funding Source: UKRI

向作者/读者索取更多资源

Diabetic foot disease is a source of major patient suffering and societal costs. Investing in evidence-based international guidelines on diabetic foot disease is likely among the most cost-effective forms of health care expenditure, provided the guidelines are outcome focused, evidence based, and properly implemented. The International Working Group on the Diabetic Foot (IWGDF) has published and updated international guidelines since 1999. The 2019 updates are based on formulating relevant clinical questions and outcomes, rigorous systematic reviews of the literature, and recommendations that are specific, and unambiguous along with their transparent rationale, all using the Grading of Recommendations Assessment Development and Evaluation (GRADE) framework. We herein describe the development of the 2019 IWGDF guidelines on the prevention and management of diabetic foot disease, which consists of six chapters, each prepared by a separate working group of international experts. These documents provide guidelines related to diabetic foot disease on prevention; offloading; peripheral artery disease; infection; wound healing interventions; and classification of diabetic foot ulcers. Based on these six chapters, the IWGDF Editorial Board also produced a set of practical guidelines. Each guideline underwent extensive review by the members of the IWGDF Editorial Board as well as independent international experts in each field. We believe that adoption and implementation of the 2019 IWGDF guidelines by health care providers, public health agencies, and policymakers will result in improved prevention and management of diabetic foot disease and a subsequent worldwide reduction in the patient and societal burden this disease causes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Endocrinology & Metabolism

Do we screen, examine or assess to identify the at-risk foot in diabetes-time for agreed terms and definitions?

Jennifer A. Pallin, Jaap J. Van Netten, Patricia M. Kearney, Sean F. Dinneen, Claire M. Buckley

DIABETIC MEDICINE (2023)

Article Endocrinology & Metabolism

Cost-effectiveness of guideline-based care provision for patients with diabetes-related foot ulcers: A modelled analysis using discrete event simulation

Yuqi Zhang, Hannah E. Carter, Peter A. Lazzarini, Susanna Cramb, Rosana Pacella, Jaap J. van Netten, Qinglu Cheng, Patrick H. Derhy, Ewan M. Kinnear, Steven M. McPhail

Summary: The provision of guideline-based care for patients with diabetes-related foot ulcers is currently suboptimal. This study shows that increasing the proportion of patients receiving guideline-based care can lead to cost savings and improved patient outcomes. Strategies to increase the uptake of guideline-based care are necessary.

DIABETIC MEDICINE (2023)

Review Endocrinology & Metabolism

Global trends in the incidence of hospital admissions for diabetes-related foot disease and amputations: a review of national rates in the 21st century

Peter A. Lazzarini, Susanna M. Cramb, Jonathan Golledge, Jedidiah I. Morton, Dianna J. Magliano, Jaap J. Van Netten

Summary: Diabetic foot disease (DFD) is a major cause of hospital admissions and amputations. This review analyzed the incidence of hospital admissions for DFD conditions and diabetes-related amputations in representative populations. The findings suggest that hospital admission rates for DFD conditions are higher than amputation rates, and the hospital admission rates for DFD conditions are not decreasing in many populations. Consistent definitions and data from low- and middle-income countries should be included in future studies.

DIABETOLOGIA (2023)

Article Endocrinology & Metabolism

Standards for the development and methodology of the 2023 IWGDF guidelines

Sicco Bus, Matilde Monteiro-Soares, Fran J. Game, Jaap van Netten, Jan Apelqvist, Robert Fitridge, Eric C. Senneville, Nicolaas Schaper

Summary: The International Working Group on the Diabetic Foot (IWGDF) has published updated guidelines in 2023 on the prevention and management of diabetes-related foot disease. These guidelines cover various aspects such as prevention, classification, offloading, peripheral artery disease, infection, wound healing interventions, and Charcot neuro-osteoarthropathy. Implementing these guidelines by healthcare providers, public health agencies, and policymakers is expected to improve the management of diabetes-related foot disease and reduce the burden caused by this condition worldwide.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2023)

Article Endocrinology & Metabolism

Definitions and criteria for diabetes-related foot disease (IWGDF 2023 update)

Jaap J. A. van Netten, Sicco A. Bus, Jan Apelqvist, Pam Chen, Vivienne Chuter, Robert Fitridge, Frances J. Game, Robert J. A. Hinchliffe, Peter A. Lazzarini, Joseph Mills, Matilde Monteiro-Soares, Edgar J. G. M. Peters, Katherine M. Raspovic, Eric K. Senneville, Dane K. C. Wukich, Nicolaas C. Schaper

Summary: In order to facilitate clear communication between individuals with diabetes-related foot disease and professionals worldwide, the International Working Group on the Diabetic Foot (IWGDF) has developed a set of definitions and criteria for diabetes-related foot disease based on systematic reviews of the literature. This document describes the 2023 update of these definitions and criteria.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2023)

Review Endocrinology & Metabolism

Prevention of foot ulcers in persons with diabetes at risk of ulceration: A systematic review and meta-analysis

Jaap J. van Netten, Anita Raspovic, Lawrence A. Lavery, Matilde Monteiro-Soares, Joanne Paton, Anne Rasmussen, Isabel C. N. Sacco, Sicco A. Bus

Summary: Prevention of foot ulcers in persons with diabetes is important, and a comprehensive analysis is needed to inform healthcare professionals about effective prevention. This systematic review and meta-analysis aimed to assess the effectiveness of interventions to prevent foot ulcers in persons with diabetes at risk.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2023)

Article Endocrinology & Metabolism

Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2023 update)

Sicco A. Bus, Isabel C. N. Sacco, Matilde Monteiro-Soares, Anita Raspovic, Joanne Paton, Anne Rasmussen, Lawrence A. Lavery, Jaap J. van Netten

Summary: This is the 2023 International Working Group on the Diabetic Foot guideline on the prevention of foot ulcers in persons with diabetes. It provides recommendations for clinicians and other healthcare professionals to screen and educate patients with diabetes in order to prevent foot ulcers.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2023)

Article Endocrinology & Metabolism

Practical guidelines on the prevention and management of diabetes-related foot disease (IWGDF 2023 update)

Nicolaas J. Schaper, Jaap van Netten, Jan A. Apelqvist, Sicco Bus, Robert Fitridge, Fran Game, Matilde Monteiro-Soares, Eric Senneville, IWGDF Editorial Board

Summary: The International Working Group on the Diabetic Foot (IWGDF) has updated their practical guidelines on the prevention and management of diabetes-related foot disease. These guidelines aim to reduce the frequency of lower-extremity amputations caused by diabetes-related foot disease and provide better care for patients worldwide.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2023)

Editorial Material Endocrinology & Metabolism

Does the skin heat up before it breaks down in diabetic foot ulceration?

Wouter B. aan de Stegge, Jaap J. Van Netten, Sicco A. Bus

Summary: This study aimed to investigate if foot ulcers in people with diabetes and foot ulcer history are preceded by increased skin temperature. The results showed that the majority of the ulcers did not heat up before the occurrence, questioning the association between foot temperature increase and ulcer development.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2023)

Review Endocrinology & Metabolism

Clinical and biomechanical effectiveness of foot-ankle exercise programs and weight-bearing activity in people with diabetes and neuropathy: A systematic review and meta-analysis

Jaap J. van Netten, Isabel C. N. Sacco, Lawrence Lavery, Matilde Monteiro-Soares, Joanne Paton, Anne Rasmussen, Anita Raspovic, Sicco A. Bus

Summary: This study aimed to summarize and analyze the effectiveness of foot-ankle exercise programs for people with diabetes at risk of foot ulceration. The results showed that an 8-12 week foot-ankle exercise program may improve ankle joint and first metatarsal-phalangeal joint range of motion and alleviate neuropathy symptoms. However, this exercise program may not prevent or cause diabetes-related foot ulceration.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2023)

Article Chemistry, Analytical

The Validity and Reliability of Self-Reported Adherence to Using Offloading Treatment in People with Diabetes-Related Foot Ulcers

Anas Ababneh, Kathleen Finlayson, Helen Edwards, David G. Armstrong, Bijan Najafi, Jaap J. van Netten, Peter A. Lazzarini

Summary: This study aimed to assess the validity and reliability of self-reported adherence to using removable cast walker (RCW) offloading treatment among people with diabetes-related foot ulcers (DFUs). The results showed that self-reported adherence was higher than objectively measured adherence, indicating poor agreement between the two measures. Therefore, clinicians and researchers should use objective measures to assess offloading adherence in patients.

SENSORS (2023)

Article Chemistry, Analytical

Self-Monitoring Diabetes-Related Foot Ulcers with the MyFootCare App: A Mixed Methods Study

Bernd Ploderer, Damien Clark, Ross Brown, Joel Harman, Peter A. Lazzarini, Jaap J. Van Netten

Summary: People with DFUs need to consistently perform self-care to promote healing, but it can be difficult to detect improvements. To address this, a mobile app called MyFootCare was developed to self-monitor DFU healing progression. The study evaluates the engagement and perceived value of MyFootCare over 3 months for people with plantar DFUs. Results showed that most participants found MyFootCare valuable for monitoring progress and reflecting on self-care events, but engagement varied due to facilitators and barriers. Further improvements and clinical outcome testing are needed.

SENSORS (2023)

Article Medicine, Research & Experimental

The efficacy of flexor tenotomy to prevent recurrent diabetic foot ulcers (DIAFLEX trial): Study protocol for a randomized controlled trial

M. A. Mens, T. E. Busch-Westbroekb, S. A. Bus, J. J. van Nettenb, R. H. H. Wellenberg, G. J. Streekstrac, M. Maas, M. Nieuwdorpd, G. M. M. J. Kerkhoffse, S. A. S. Stufkense

Summary: Foot ulcers are a significant issue in diabetes patients, often leading to amputations. This study aims to evaluate the effectiveness of tendon tenotomy in preventing toe ulcer recurrence in patients with diabetes and a history of toe ulcers.

CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS (2023)

Review Endocrinology & Metabolism

Effectiveness of bedside investigations to diagnose peripheral artery disease among people with diabetes mellitus: A systematic review

Vivienne Chuter, Nicolaas Schaper, Joseph Mills, Robert Hinchliffe, David Russell, Nobuyoshi Azuma, Christian-Alexander Behrendt, Edward J. Boyko, Michael S. Conte, Misty Humphries, Lee Kirksey, Katharine C. McGinigle, Sigrid Nikol, Joakim Nordanstig, Vincent Rowe, Jos C. van den Berg, Maarit Venermo, Robert Fitridge

Summary: Early diagnosis and ongoing monitoring and treatment of peripheral artery disease (PAD) is crucial for reducing the risk of foot ulcer development, non-healing of wounds, infection, amputation, and cardiovascular complications in patients with diabetes. Various non-invasive bedside tests are available for diagnosing PAD, but the most accurate test and its reliability for ongoing monitoring are still uncertain. This systematic review aimed to determine the diagnostic accuracy of non-invasive bedside tests for identifying PAD and their reliability in adults with diabetes. The review included 40 studies on diagnostic accuracy and 7 studies on reliability. Ankle-brachial index (ABI) was the most investigated test. The review found that an ABI <0.9 increases the likelihood of disease, while an ABI within the normal range (≥0.90 and <1.3) does not exclude PAD. Toe-brachial index (TBI) and Doppler waveforms in the pedal arteries were also associated with PAD presence. Several bedside tests showed acceptable reliability, but the margin of error was wide. No single or combination of bedside tests demonstrated superior diagnostic accuracy for PAD in patients with diabetes. However, an ABI of 1.3, TBI <0.70, and absent or monophasic pedal Doppler waveforms can help identify the presence of disease.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2023)

Review Endocrinology & Metabolism

Performance of non-invasive bedside vascular testing in the prediction of wound healing or amputation among people with foot ulcers in diabetes: A systematic review

Vivienne Chuter, Nicolaas Schaper, Robert Hinchliffe, Joseph Mills, Nobuyoshi Azuma, Christian-Alexander Behrendt, Edward J. Boyko, Michael S. Conte, Misty Humphries, Lee Kirksey, Katharine C. McGinigle, Sigrid Nikol, Joakim Nordanstig, Vincent Rowe, Russell David, Jos C. van den Berg, Maarit Venermo, Robert Fitridge

Summary: This systematic review aimed to determine the performance of non-invasive bedside tests for predicting the outcomes of DFU healing, minor amputation, and major amputation in people with diabetes and DFU or gangrene. The results showed that a toe pressure of ≥30 mmHg, TcPO2 of ≥25 mmHg, and skin perfusion pressure of ≥40 mmHg were associated with a moderate to large increase in the likelihood of DFU healing. However, there is limited research on the prognostic capacity of bedside testing for healing post-minor amputation or major amputation in people with DFU. Current evidence suggests that an ABI <0.4 may be associated with a large increase in the risk of major amputation.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2023)

暂无数据